These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3107958)

  • 1. The post-antimicrobial suppressive effect of quinolone agents.
    Neu HC; Kumada T; Chin NX; Mandell W
    Drugs Exp Clin Res; 1987; 13(2):63-7. PubMed ID: 3107958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].
    Allocati N; Catamo G; Cellini L
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1927-33. PubMed ID: 6440583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ
    Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
    Baltch AL; Sutphen NT; Smith RP; Conley PE
    Clin Ther; 1984; 7(1):73-80. PubMed ID: 6440708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with ciprofloxacin in vitro and in vivo.
    Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
    Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidis.
    Felmingham D; Wall RA
    Drugs Exp Clin Res; 1985; 11(7):427-9. PubMed ID: 3939218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of urinary pathogens to quinolones compared to other antimicrobial agents.
    Osman LM; Sabbour MS; el-Baz F
    Chemioterapia; 1987 Jun; 6(2 Suppl):147-8. PubMed ID: 3151335
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens.
    Gesu GP; Eftimiadi C; Debbia E; Schito GC
    Drugs Exp Clin Res; 1987; 13(2):79-84. PubMed ID: 3556122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-antibiotic effect of three quinolones against gram negative isolates from urine.
    Alados JC; Gutierrez J; Garcia F; Liebana J; Piedrola G
    Med Lab Sci; 1990 Oct; 47(4):272-7. PubMed ID: 2283929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Chanal M; Cluzel M; Fleurette J; Forey F; Thabaut A; Meyran M; Vandekerkove M; Sicard D; Acar JF; Kitzis MD; Veron M; Fauchere JL
    Pathol Biol (Paris); 1983 Jun; 31(6):504-8. PubMed ID: 6348657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
    Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.